Document is current

Article History

Accepted: 17 October 2022

First Online: 18 November 2022

Declarations

:

: Medical writing and editorial assistance, provided by Ashfield MedComms, an Inizio Company, was funded by Novartis Pharmaceuticals Corporation.

: Neal D. Shore reports consulting fees from Abbvie, Amgen, Astellas, AstraZeneca, Bayer, BMS, Boston Scientific, Clarity, Clovis Oncology, Cold Genesys, Dendreon, Exact Imaging, Exact Sciences, FerGene, Foundation Medicine, Genesis Care, Invitae, Janssen, Lantheus, Lilly, MDxhealth, Merck, Myovant, Myriad, Nymox, Pacific Edge, Pfizer, Phosphorous, Photocure, Propella, PreView, Sanofi Genzyme, Sema4, Specialty Networks, Sesen Bio, Telix, Tempus, Tolmar, Urogen, and Vaxiion; and payment for expert testimony from Ferring. Alicia K. Morgans has received grants from Bayer, Myovant, Pfizer, and the Prostate Cancer Foundation; has received consulting fees from Advanced Accelerator Applications, Astellas, AstraZeneca, Bayer, Blue Earth Diagnostics, Exelixis, Janssen, Lantheus Medical Imaging, Merck, Myovant Sciences, Myriad Genetics, Novartis, and Sanofi; has received payment or honoraria for lectures, presentations, speaker bureaus, publication writing, or educational events from Astellas, Clovis, Janssen, Myovant, Sanofi, and Telix; has received travel support from Sanofi; has participated in a data safety monitoring board or advisory board for Bayer and Myovant; has received honoraria from Advanced Accelerator Applications, Astellas Pharma, Astellas, AstraZeneca, Bayer, Clovis Oncology, Exelixis, Genentech, Janssen, Janssen Oncology, Merck, Myovant Sciences, Pfizer, and Sanofi; and has received research funding from Astellas, AstraZeneca, Bayer, Dendreon, Genentech, Myovant Sciences, Sanofi, and Seattle Genetics. Ghassan El-Haddad is a consultant for Bayer HealthCare, Boston Scientific, Canon Medical Systems Corporation, Curium Pharma, Novartis, and Terumo Corporation. Matthew Abramowitz reports travel support from AlphaTau; honoraria from Varian Medical Systems; and grant support from Varian Medical Systems. Sandy Srinivas has no conflicts to disclose.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: All authors contributed to developing the first draft of the manuscript, critically revising the manuscript, and approving the final version for submission.